Dominance of mutations in epigenetic regulators and a diversity of signaling alterations in blast-phase BCR::ABL1-negative myeloproliferative neoplasms

被引：0

作者：

Gurban, Petruta ^{[1
,2
]}

Mambet, Cristina ^{[1
,3
,4
]}

Botezatu, Anca ^{[5
]}

Necula, Laura G. ^{[1
]}

Matei, Lilia ^{[1
]}

Neagu, Ana Iulia ^{[1
,6
]}

Pitica, Ioana ^{[1
]}

Ataman, Marius ^{[1
]}

Tatic, Aurelia ^{[1
,3
,7
]}

Bardas, Alexandru ^{[1
,3
,7
]}

Gaman, Mihnea A. ^{[1
,3
,7
]}

Dobrea, Camelia ^{[3
,7
]}

Dragomir, Mihaela ^{[7
]}

Ghimici, Cecilia ^{[8
]}

Angelescu, Silvana ^{[3
,8
]}

Barbu, Doina ^{[8
]}

Stanca, Oana ^{[3
,8
]}

Danila, Marina ^{[8
]}

Berbec, Nicoleta ^{[3
,8
]}

Colita, Andrei ^{[3
,8
]}

Vladareanu, Ana Maria ^{[3
,4
]}

Nedeianu, Saviana ^{[1
]}

Chivu-Economescu, Mihaela ^{[1
]}

Bleotu, Coralia ^{[1
]}

Coriu, Daniel ^{[1
,3
,7
]}

Sepulchre, Elise ^{[9
]}

Anton, Gabriela ^{[5
]}

Diaconu, Carmen C. ^{[1
]}

Constantinescu, Stefan N. ^{[9
,10
,11
,12
]}

机构：

[1] Romanian Acad, Stefan S Nicolau Inst Virol, Cellular & Mol Pathol Dept, Bucharest, Romania

[2] Cytogenom Med Lab, Bucharest, Romania

[3] Carol Davila Univ Med & Pharm, Fac Med, Dept Radiol Oncol & Hematol, Bucharest, Romania

[4] Emergency Univ, Clin Hosp, Hematol Dept, Bucharest, Romania

[5] Romanian Acad, Stefan S Nicolau Inst Virol, Mol Virol Dept, Bucharest, Romania

[6] Carol Davila Univ Med & Pharm, Fac Med, Infect Dis Epidemiol Microbiol Parasitol Virol Dia, Bucharest, Romania

[7] Fundeni Clin Inst, Ctr Hematol & Bone Marrow Transplantat, Bucharest, Romania

[8] Coltea Clin Hosp, Hematol Dept, Bucharest, Romania

[9] Catholic Univ Louvain, de Duve Inst, Brussels, Belgium

[10] Ludwig Inst Canc Res Brussels, SIGN Cell Signalling & Mol Hematol, Brussels, Belgium

[11] WEL Res Inst, Walloon Excellence Life Sci & Biotechnol WELBIO De, Wavre, Belgium

[12] Univ Oxford, Ludwig Inst Canc Res, Nuffield Dept Med, Oxford, England

来源：

AMERICAN JOURNAL OF HEMATOLOGY | 2025年 / 100卷 / 01期

关键词：

D O I：

10.1002/ajh.27503

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：168 / 171

页数：4

共 50 条

[31] Basophilia Predicts Poorer Outcomes in BCR-ABL1-Negative Myeloproliferative Neoplasms
Yuen, Lisa
Gogakos, Tasos
Boiocchi, Leonardo
Hobbs, Gabriela
Hasserjian, Robert
LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 1048 - 1049
[32] Immunophenotypic Aberrancy on Basophils, a Biomarker for BCR-ABL1 Negative Myeloproliferative Neoplasms
Chu, Andrew
Kumar, Kirthi
Monaghan, Sara A.
Fuda, Franklin
Chen, Weina
MODERN PATHOLOGY, 2016, 29 : 340A - 340A
[33] THE FREQUENCY AND PROGNOSTIC OF EZH2 MUTATIONS IN PATIENTS WITH BCR-ABL-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Polushkina, L.
Martynkevich, I.
Petrova, E.
Martynenko, L.
Cybakova, N.
Petrova, M.
Shabanova, E.
Zotova, I.
Zamotina, T.
Fominykh, M.
Shuvaev, V.
Abdulkadyrov, K.
HAEMATOLOGICA, 2014, 99 : 660 - 660
[34] IDH1/2 inhibitor monotherapy in blast-phase myeloproliferative neoplasms: A multicentre experience
Gangat, Naseema
Ajufo, Helen
Abdelmagid, Maymona
Karrar, Omer
McCullough, Kristen
Badar, Talha
Foran, James
Palmer, Jeanne
Alkhateeb, Hassan
Mangaonkar, Abhishek
Kuykendall, Andrew
Rampal, Raajit K.
Tefferi, Ayalew
BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (03) : E87 - E92
[35] JAK2 V617F and Exon 12 Genetic Variations in Korean Patients with BCR/ABL1-negative Myeloproliferative Neoplasms
Kim, Jeong Tae
Cho, Yong Gon
Choi, Sam Im
Lee, Young Jin
Kim, Hye Ran
Jang, Sook Jin
Moon, Dae Soo
Park, Young Jin
Park, Geon
KOREAN JOURNAL OF LABORATORY MEDICINE, 2010, 30 (06): : 567 - 574
[36] The Prevalence of JAK2, MPL, and CALR Mutations in Chinese Patients With BCR-ABL1-Negative Myeloproliferative Neoplasms
Lin, Yani
Liu, Enbin
Sun, Qi
Ma, Jiao
Li, QingHua
Cao, Zeng
Wang, Jun
Jia, Yujiao
Zhang, Hongju
Song, Zhen
Ai, Xiaofei
Shi, Lihui
Feng, Xiaofang
Li, Chenwei
Wang, Jianxiang
Ru, Kun
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (01) : 165 - 171
[37] The BCR-ABL1-negative myeloproliferative neoplasms: a review of JAK inhibitors in the therapeutic armamentarium
Griesshammer, Martin
Sadjadian, Parvis
EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (18) : 1929 - 1938
[38] Contemporary management of patients with BCR-ABL1-negative myeloproliferative neoplasms during pregnancy
Griesshammer, Martin
Sadjadian, Parvis
Wille, Kai
EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (09) : 697 - 706
[39] CO-OCCURRING MUTATIONAL PATTERN IN BCR-ABL1-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
Lee, Young Kyung
Park, Sangkeun
Cho, Yonggeun
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 67 - 67
[40] Risk-adapted treatment of chronic BCR-ABL1 negative myeloproliferative neoplasms
Heidel, Florian H.
Doehner, Konstanze
ONKOLOGE, 2019, 25 (11): : 985 - 993

← 1 2 3 4 5 →